PRESS RELEASE   FROM THE MINISTRY OF HEALTH AND HUMAN SERVICES Providenciales Turks and Caicos Islands, 8th February 2025 ...

A survey of the nation's oncologists showed that professional burnout has reached a new high (59% vs 45% in 2013), and fewer ...

Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell carcinoma (ccRCC), the most common type of kidney cancer among adults.

Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still ...

Recent scientific studies have shown promising advancements in medical treatments. A personalized vaccine significantly ...

A new HPV vaccine induced regression of precancerous cervical lesions in 50% of patients and led to viral clearance in some ...

The incidence rate of cases increased 6.7% per year on average between 2011 and 2021, the JAMA-published research revealed.

A personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to ...

The FDA approved Datroway to treat metastatic or unresectable HR+/HER2- breast cancer in people who have tried standard chemo ...

Vaccines generated using the cells left over after tumour removal surgery could help to keep patients from redeveloping ...

For men with benign prostatic hyperplasia (BPH), transurethral Holmium Laser of the Prostate (HoLEP) with Double-n Technology ...

After their advanced kidney tumors were surgically removed, nine patients were protected from the cancer returning thanks to ...